Login

durvalumab

Medicine Status PIL SPC XPIL EDM - HCP Legal Category Active Ingredient(s) Company IMFINZI 50 mg/mL concentrate for solution for infusion
No Recent Update
 PIL 15/09/21 SPC 15/09/21 No-A
durvalumab
AstraZeneca Pharmaceuticals (Ireland) DAC